A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 30 Apr 2018
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Acronyms ACCESS IUS
- Sponsors Medicines360
- 30 Apr 2018 Results assessing five-year efficacy and safety data for Liletta, were presented at the 66th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
- 30 Apr 2018 According to an Allergan media release, five-year data presented at the American College of Obstetricians and Gynecologists (ACOG) 2018 annual clinical and scientific meeting.
- 30 Apr 2018 Five-years results presented in a Medicines360 media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History